The TGA has approved a new medicine that works to remove the build-up of a protein in the brain that can lead to memory loss and impaired thinking.
TGA approves first-of-a-kind medicine for early symptomatic Alzheimer’s disease
May 21, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Advocacy group 'pleading' with the NSW Government to establish Men B vaccine program
June 10, 2025 - - Latest News -
New study reveals superior efficacy of cell-based flu vaccine
June 10, 2025 - - Latest News -
Medicines Australia says delayed listings would not be a surprising response
June 10, 2025 - - Latest News -
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 - - Latest News -
You certainly couldn't accuse this system of haste, and this might need ministerial intervention
June 9, 2025 - - Latest News -
Early intervention on chronic kidney disease would deliver economic boost
June 8, 2025 - - Latest News -
Australian Dementia Network, Monash University and Lilly sign research collaboration
June 6, 2025 - - Latest News